ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Tenofovir

Also written as “Tenofovir disoproxil fumarate”, “Tenofovir DF” and “tenofovir”.

Its studies are mostly in Hepatitis B, Chronic · HIV Infections · Hepatitis B · Acquired Immunodeficiency Syndrome · Hepatitis C, led by 12 companies.

Drug pageTenofovir: every studyMany companies study it; this page follows only the 53 they lead. All 291 studies, academic ones too, with its approvals and label.
Furthest: phase 4, since Mar 23, 200553 company-led studies, 1 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Gilead Sciences291 open or runningphase 4since Mar 23, 2005Nov 2, 1999none ahead
GlaxoSmithKlineits history only90 open or runningphase 4since May 31, 2002May 31, 2002none ahead
Hoffmann-La Rocheits history only30 open or runningphase 3since Mar 16, 2010Aug 19, 2009none ahead
Laboratorio Elea Phoenixits history only20 open or runningphase 4since Oct 10, 2017Oct 19, 2015none ahead
Novartisits history only20 open or runningphase 4since Dec 7, 2006Dec 7, 2006none ahead
Samjin Pharmaceuticalits history only20 open or runningphase 4since Feb 25, 2022Feb 25, 2022none ahead
Boryung Pharmaceuticalits history only10 open or runningphase 1since Sep 29, 2016Sep 29, 2016none ahead
Daewoong Pharmaceuticalits history only10 open or runningphase 4since Mar 27, 2018Mar 27, 2018none ahead
Dong-A STits history only10 open or runningphase 1since Sep 22, 2015Sep 22, 2015none ahead
New Discoveryits history only10 open or runningphase 4since Mar 18, 2018Mar 18, 2018none ahead

Also a collaborator on its studies: C&R Research, Almedis and Bristol-Myers Squibb.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Gilead Sciences only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). An open circle marks the day WHO proposed its name. Dates ahead are the sponsors’ estimates.

Before these, 13 studies since Nov 2, 1999.

  1. May 10, 2006Phase 4 study in HIV InfectionsNCT00324688 · 60 enrolled · Germany
  2. Jul 13, 2006Phase 3 study in HIV InfectionsNCT00352053 · 87 enrolled · Brazil, Panama
  3. Aug 16, 2006Phase 4 study in HIV InfectionsNCT00365612 · 300 enrolled · United States, Puerto Rico
  4. Jan 3, 2007Phase 3 study in HIV InfectionsNCT00528957 · 97 enrolled · United States, Panama, United Kingdom
  5. Feb 4, 2008Phase 4 study in HIV InfectionsNCT00615745 · 115 enrolled · United Kingdom
  6. Mar 20, 20082 phase 4 studies in HIV InfectionsNCT00643968, NCT00648817
  7. Mar 27, 2008Phase 2 study in LipodystrophyNCT00647946 · 100 enrolled · United Kingdom
  8. Aug 13, 2008Phase 4 study in Hepatitis B, ChronicNCT00736190 · 90 enrolled · United States
  9. Aug 13, 20082 phase 3 studies in Hepatitis BNCT00734162, NCT00737568
  10. Nov 4, 2010Phase 2 study in Hepatitis BNCT01334567 · 30 enrolled · Taiwan
  11. Jan 13, 2011Phase 4 study in Hepatitis B, ChronicNCT01277601 · 751 enrolled · United States, Australia, Canada and more
  12. Jul 25, 2012Phase 3 study in Hepatitis B, ChronicNCT01651403 · 90 enrolled · United States, India, Romania and more
  13. Aug 21, 2012Phase 1 study in Hepatitis B, ChronicNCT01671787 · 51 enrolled · United States, Australia, Canada and more
  14. Jun 17, 2015Phase 4 study in Hepatitis BNCT02479880 · 30 enrolled · Belgium, France, Greece and more
  15. Jun 9, 2016Named tenofovirINNProposed as its International Nonproprietary Name in WHO's List 115

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 29 Gilead Sciences leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT02479880Hepatitis B · Belgium, France, Greece and more4TerminatedFeb 28, 201830
NCT01671787Hepatitis B, Chronic · United States, Australia, Canada and more1CompletedApr 201351
NCT01651403Hepatitis B, Chronic · United States, India, Romania and more3Active, not recruitingAug 7, 201790
NCT01277601Hepatitis B, Chronic · United States, Australia, Canada and more4CompletedAug 2014751
NCT01334567Hepatitis B · Taiwan2CompletedDec 201330
NCT00737568Hepatitis B · United States, Austria, Bulgaria and more3CompletedNov 2011280
NCT00736190Hepatitis B, Chronic · United States4CompletedJul 201090
NCT00734162Hepatitis B · United States, Bulgaria, France and more3CompletedMar 2011106
NCT00648817HIV Infections · United Kingdom4CompletedNov 20078
NCT00647946Lipodystrophy · United Kingdom2CompletedOct 2004100
NCT00643968HIV Infections · France4CompletedJun 2005140
NCT00615745HIV Infections · United Kingdom4CompletedNov 2010115
NCT00528957HIV Infections · United States, Panama, United Kingdom3CompletedApr 6, 200997
NCT00365612HIV Infections · United States, Puerto Rico4CompletedOct 2007300
NCT00352053HIV Infections · Brazil, Panama3CompletedSep 200887
NCT00324688HIV Infections · Germany4Completed60
NCT00307489Hepatitis B, Chronic · United States, France, Germany and more2CompletedJan 2008106
NCT00298363Hepatitis B, Chronic · United States, Canada, France and more2CompletedApr 2011112
NCT00158821HIV Infections3CompletedDec 2001180
NCT00112047HIV Infections · United States3CompletedFeb 2005517
NCT00106379HIV Infections · United States4Completed52
NCT00016588HIV Infections · United States–Completed
NCT00011089HIV Infections · United States–UNKNOWN
NCT00007436HIV Infections · United States3UNKNOWN
NCT00002453HIV Infections · United States–Completed300
NCT00002450HIV Infections · United States, Puerto Rico3Completed600
NCT00002415HIV Infections · United States2Completed175
NCT00002396HIV Infections · United States1UNKNOWN60
NCT00002180HIV Infections · United States1Completed

How it is read

Names in the registry

  • “Tenofovir disoproxil fumarate”, 13 entries
  • “Tenofovir”, 7 entries
  • “Tenofovir DF”, 6 entries
  • “tenofovir”, 5 entries
  • “TDF”, 4 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.